Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also …
Over the last 12 months, insiders at Ekso Bionics Holdings, Inc. have bought $0 and sold $0 worth of Ekso Bionics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Ekso Bionics Holdings, Inc. have bought $15,477 and sold $156,770 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,032 shares for transaction amount of $5,005 was made by Lathan Corinna (director) on 2023‑11‑02.
2023-11-02 | director | 4,032 0.0281% | $1.24 | $5,005 | +8.87% | |||
2023-08-23 | director | 5,500 0.0402% | $0.95 | $5,222 | +42.40% | |||
2023-08-17 | Sale | President & COO | 37,446 0.2868% | $1.00 | $37,281 | +35.35% | ||
2023-08-17 | Sale | Chief Financial Officer | 12,784 0.0979% | $1.00 | $12,728 | +35.35% | ||
2023-08-10 | director | 4,201 0.0332% | $1.25 | $5,251 | +14.10% | |||
2023-05-24 | Sale | Executive Chair | 45,660 0.3393% | $1.44 | $65,874 | -6.85% | ||
2023-05-08 | Sale | Chief Operating Officer | 3,435 0.0259% | $1.57 | $5,401 | -12.74% | ||
2022-12-04 | Sale | Executive Chair | 10,576 0.084% | $1.28 | $13,492 | |||
2022-11-21 | Sale | CEO & Chairman | 5,787 0.0421% | $1.26 | $7,312 | +3.79% | ||
2022-11-16 | Sale | Senior VP Product Development | 782 0.0059% | $1.28 | $1,003 | +6.01% | ||
2022-11-16 | Sale | Chief Financial Officer | 723 0.0055% | $1.28 | $927 | +6.01% | ||
2022-10-24 | Sale | CEO & Chairman | 5,921 0.0449% | $1.29 | $7,619 | +6.98% | ||
2022-08-31 | Sale | Senior VP Product Development | 5,873 0.0442% | $2.31 | $13,587 | -38.94% | ||
2022-08-21 | Sale | CEO & Chairman | 5,572 0.0412% | $2.20 | $12,278 | |||
2022-08-03 | Sale | InterimChief Financial Officer | 1,675 0.0127% | $1.80 | $3,021 | -19.23% | ||
2022-07-21 | Sale | CEO & Chairman | 5,662 0.0412% | $1.75 | $9,909 | -19.02% | ||
2022-07-18 | Sale | InterimChief Financial Officer | 98 0.0007% | $1.71 | $167 | -13.29% | ||
2022-06-30 | Sale | President & COO | 4,997 0.0399% | $1.72 | $8,595 | -5.45% | ||
2022-06-21 | Sale | CEO & Chairman | 5,330 0.0418% | $1.74 | $9,259 | -8.72% | ||
2022-06-15 | Sale | CEO & Chairman | 6,911 0.0542% | $1.90 | $13,118 | -15.96% |
SHERMAN STEVEN | Executive Chair | 364913 1.6588% | $0.61 | 1 | 12 | +32.03% |
Lathan Corinna | director | 147990 0.6727% | $0.61 | 3 | 0 | |
Peurach Jack | Chief Executive Officer | 78120 0.3551% | $0.61 | 1 | 1 | +39.84% |
SCHEDER-BIESCHIN MAX | Chief Financial Officer | 32371 0.1472% | $0.61 | 2 | 0 | +1.86% |
Looby Thomas | President & CEO | 20315 0.0923% | $0.61 | 2 | 0 | +3.84% |
Kent Lake Capital LLC | $810,628.00 | 3.28 | 596,050 | +322.26% | +$618,653.12 | 0.37 | |
The Vanguard Group | $776,771.00 | 3.14 | 571,155 | +30.72% | +$182,552.85 | <0.0001 | |
Geode Capital Management | $150,137.00 | 0.61 | 110,349 | +12.08% | +$16,182.56 | <0.0001 | |
Renaissance Technologies | $111,000.00 | 0.45 | 81,716 | +2.13% | +$2,309.22 | <0.0001 | |
BlackRock | $74,459.00 | 0.3 | 54,749 | -1.27% | -$957.45 | <0.0001 |